| Aug 8 |
Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
|
| Jul 23 |
Ensysce Biosciences Provides Mid-Year 2024 Update
|
| Jul 9 |
Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
|
| Jun 27 |
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
|
| Jun 25 |
Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
|
| Jun 6 |
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
|
| Jun 3 |
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
|
| May 28 |
Ensysce Biosciences regains Nasdaq compliance
|
| May 28 |
Ensysce Biosciences Regains Compliance with Nasdaq
|
| May 20 |
Sector Update: Health Care Stocks Softer Late Afternoon
|
